["癌症檢測初創公司 C2i Genomics 與以色列頂級醫院特拉維夫 Sourasky 醫療中心合作，利用基於雲的人工智能解決方案進行早期癌症檢測。","C2i Genomics 專注於全基因組微小殘留病（MRD）檢測，以提高癌症的檢測和監測能力。","合作將推動醫院內部研究和臨牀試驗，並促進製藥公司的藥物開發。"]
{"1":"癌症檢測初創公司 C2i Genomics 與以色列頂級醫院特拉維夫 Sourasky 醫療中心合作，利用基於雲的人工智能解決方案進行早期癌症檢測。","2":"C2i Genomics 專注於全基因組微小殘留病（MRD）檢測，以提高癌症的檢測和監測能力。","3":"合作將推動醫院內部研究和臨牀試驗，並促進製藥公司的藥物開發。"}
Bytedance
-
輸入tokens/百萬
輸出tokens/百萬
上下文長度
Xai
$1.4
$10.5
256
Chatglm
%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20fill:%20%23061b40;%20}%20.st1%20{%20fill:%20%23306af1;%20}%20.st2%20{%20fill:%20%235ce5cf;%20}%20%3c/style%3e%3c/defs%3e%3cg%3e%3cpath%20class='st0'%20d='M55,10.5h9v3h-9v9h12V7.5h-12v3ZM64,19.5h-6v-3h6v3Z'/%3e%3cpolygon%20class='st0'%20points='69%2016.5%2078%2016.5%2078%2019.5%2069%2019.5%2069%2022.5%2081%2022.5%2081%2013.5%2072%2013.5%2072%2010.5%2081%2010.5%2081%207.5%2069%207.5%2069%2016.5'/%3e%3cpolygon%20class='st0'%20points='95%2010.5%2095%207.5%2083%207.5%2083%2022.5%2095%2022.5%2095%2019.5%2086%2019.5%2086%2016.5%2095%2016.5%2095%2013.5%2086%2013.5%2086%2010.5%2095%2010.5'/%3e%3cpath%20class='st0'%20d='M40,1.5v21h11.6l1.4-1.4v-7.6h0c0,0-1.4-1.5-1.4-1.5l1.4-1.4V2.9l-1.4-1.4h-11.6ZM50,19.5h-7v-6h7v6ZM50,10.5h-7v-6h7v6Z'/%3e%3c/g%3e%3cpath%20class='st1'%20d='M23.1,24L14.7,4.8l-4.9,11.2h3.8l-1.8,4H3.3L12.1,0H2C.9,0,0,.9,0,2v20c0,1.1.9,2,2,2h21.1Z'/%3e%3cpath%20class='st2'%20d='M34,0h-16.8l10.6,24h6.2c1.1,0,2-.9,2-2V2C36,.9,35.1,0,34,0ZM32.5,20h-4V4h4v16Z'/%3e%3c/svg%3e)
